- Corporate Officers - G
- Gilbert Halley E
Insider Trading History of Gilbert Halley E
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gilbert Halley E since 2016.
This trader's CIK number is 1601360.
At the time of last reporting, Gilbert Halley E was the Officer of Arcutis Biotherapeutics, Inc.. (stock ticker symbol ARQT).
Also see all insider trading activities at Arcutis Biotherapeutics, Inc..
Note that in the past
Gilbert Halley E also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Vaxcyte, Inc. (PCVX) by Gilbert Halley E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | PCVX | 0 | $0 | 18,200 | $1,328,600 | 18,200 | $97,370 |
Yearly summary of insider trading at Ironwood Pharmaceuticals Inc (IRWD) by Gilbert Halley E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | IRWD | 0 | $0 | 75,328 | $901,264 | 60,000 | $601,200 |
| 2019 | IRWD | 0 | $0 | 34,297 | $389,262 | 40,449 | $197,595 |
| 2018 | IRWD | 0 | $0 | 37,292 | $697,115 | 29,551 | $144,504 |
| 2017 | IRWD | 0 | $0 | 77,424 | $1,402,808 | 72,385 | $272,167 |
| 2016 | IRWD | 0 | $0 | 34,275 | $481,652 | 29,865 | $112,292 |
Yearly summary of insider trading at Arcutis Biotherapeutics, Inc. (ARQT) by Gilbert Halley E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ARQT | 0 | $0 | 16,532 | $455,440 | 12,220 | $91,772 |
Insider trading activities at 3 companies by Gilbert Halley E:
1. Vaxcyte, Inc. (PCVX)
2. Ironwood Pharmaceuticals Inc (IRWD)
3. Arcutis Biotherapeutics, Inc. (ARQT)
Table 1. Insider trading of Vaxcyte, Inc. (PCVX) by Gilbert Halley E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-03 | PCVX | Option Ex | 18,200 | 5.35 | 97,370 |
| 2024-06-03 | PCVX | Sale | 18,200 | 73.00 | 1,328,600 |
Table 2. Insider trading of Ironwood Pharmaceuticals Inc (IRWD) by Gilbert Halley E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-02-21 | IRWD | Sale | 15,328 | 11.63 | 178,264 |
| 2020-01-31 | IRWD | Sale | 60,000 | 12.05 | 723,000 |
| 2020-01-31 | IRWD | Option Ex | 60,000 | 10.02 | 601,200 |
| 2019-07-26 | IRWD | Option Ex | 20,000 | 4.88 | 97,600 |
| 2019-07-26 | IRWD | Sale | 20,000 | 10.00 | 200,000 |
| 2019-05-10 | IRWD | Sale | 4,055 | 10.53 | 42,699 |
| 2019-02-20 | IRWD | Sale | 10,157 | 14.31 | 145,346 |
| 2019-02-21 | IRWD | Sale | 85 | 14.32 | 1,217 |
| 2019-01-30 | IRWD | Option Ex | 20,449 | 4.89 | 99,995 |
| 2018-07-03 | IRWD | Option Ex | 29,551 | 4.89 | 144,504 |
| 2018-07-03 | IRWD | Sale | 29,551 | 19.75 | 583,632 |
| 2018-02-21 | IRWD | Sale | 7,741 | 14.66 | 113,483 |
| 2017-06-22 | IRWD | Option Ex | 35,000 | 3.76 | 131,600 |
| 2017-06-22 | IRWD | Sale | 35,000 | 19.75 | 691,250 |
| 2017-02-22 | IRWD | Sale | 5,039 | 16.94 | 85,360 |
| 2017-02-14 | IRWD | Sale | 37,385 | 16.75 | 626,198 |
| 2017-02-14 | IRWD | Option Ex | 37,385 | 3.76 | 140,567 |
| 2016-11-11 | IRWD | Option Ex | 14,000 | 3.76 | 52,640 |
| 2016-11-11 | IRWD | Sale | 14,000 | 16.75 | 234,500 |
| 2016-05-25 | IRWD | Option Ex | 15,865 | 3.76 | 59,652 |
| 2016-05-25 | IRWD | Sale | 20,275 | 12.19 | 247,152 |
Table 3. Insider trading of Arcutis Biotherapeutics, Inc. (ARQT) by Gilbert Halley E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-11-20 | ARQT | Option Ex | 12,220 | 7.51 | 91,772 |
| 2025-11-20 | ARQT | Sale | 16,532 | 27.55 | 455,440 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gilbert Halley E
(Officer of Arcutis Biotherapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.